Literature DB >> 25755384

Occult hepatitis C virus infection and its relevance in clinical practice.

Tram Nq Pham1, Tomasz I Michalak1.   

Abstract

Hepatitis C virus (HCV) can persist in the liver, lymphoid (immune) cells, and serum of individuals long after an apparently complete therapy-induced or a spontaneous resolution of hepatitis C. This essential asymptomatic infection, called secondary occult HCV infection (OCI), usually occurs in anti-HCV antibody reactive individuals with normal liver function tests. This infection has been identified when the nucleic acid amplification assays of enhanced sensitivity were applied for the detection of HCV genome and its replication. In addition to the secondary OCI, a form of low-level HCV-RNA-positive infection of unknown etiology coinciding with moderately elevated serum liver enzymes and progressing in the absence of anti-HCV detectable by standard clinical assays has been reported. Because of its undefined origin, it can be termed cryptogenic OCI. In this review, the general characteristics of OCI, the ways of its detection and associated controversies, and the potential clinical implications of its existence will be concisely outlined.

Entities:  

Keywords:  CHC, chronic hepatitis C; Clinical practice; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; IFN, interferon; IU, international unit; NAH, nucleic acid hybridization; OCI, occult HCV infection; PBMC, peripheral blood mononuclear cells; PCR, polymerase chain reaction; RBV, ribavirin; RNA, ribonucleic acid; SVR, sustained virological response; hepatitis C; identification of OCI; occult HCV infection

Year:  2012        PMID: 25755384      PMCID: PMC3940301          DOI: 10.1016/S0973-6883(11)60130-8

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  44 in total

1.  Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy.

Authors:  Akiko Makiyama; Yoshito Itoh; Akinori Kasahara; Yasuharu Imai; Sumio Kawata; Kentaro Yoshioka; Hirohito Tsubouchi; Kendo Kiyosawa; Shinichi Kakumu; Kiwamu Okita; Norio Hayashi; Takeshi Okanoue
Journal:  Cancer       Date:  2004-10-01       Impact factor: 6.860

2.  Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment.

Authors:  Inmaculada Castillo; Elena Rodríguez-Iñigo; Juan Manuel López-Alcorocho; Margarita Pardo; Javier Bartolomé; Vicente Carreño
Journal:  Clin Infect Dis       Date:  2006-10-05       Impact factor: 9.079

3.  Hepatitis C virus persistence after sustained virological response to antiviral therapy in patients with or without past exposure to hepatitis B virus.

Authors:  T N Q Pham; C S Coffin; N D Churchill; S J Urbanski; S S Lee; T I Michalak
Journal:  J Viral Hepat       Date:  2011-03-01       Impact factor: 3.728

4.  Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy.

Authors:  E Formann; P Steindl-Munda; H Hofer; W Jessner; U Bergholz; C Gurguta; P Ferenci
Journal:  Aliment Pharmacol Ther       Date:  2006-02-15       Impact factor: 8.171

5.  Estimating progression to cirrhosis in chronic hepatitis C virus infection.

Authors:  A J Freeman; G J Dore; M G Law; M Thorpe; J Von Overbeck; A R Lloyd; G Marinos; J M Kaldor
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

6.  Productive replication of hepatitis C virus in perihepatic lymph nodes in vivo: implications of HCV lymphotropism.

Authors:  Sampa Pal; Daniel G Sullivan; Sean Kim; K Kay-Yin Lai; John Kae; Scott J Cotler; Robert L Carithers; Brent L Wood; James D Perkins; David R Gretch
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

7.  Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients.

Authors:  Sarah L George; Bruce R Bacon; Elizabeth M Brunt; Kusal L Mihindukulasuriya; Joyce Hoffmann; Adrian M Di Bisceglie
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

8.  Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C.

Authors:  Tram N Q Pham; Sonya A MacParland; Patricia M Mulrooney; Helen Cooksley; Nikolai V Naoumov; Tomasz I Michalak
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  Recurrence of HCV infection in a sustained responder after chemotherapy for non-Hodgkin's lymphoma: successful retreatment.

Authors:  K Thomopoulos; N C Giannakoulas; A C Tsamandas; K Mimidis; E Fragopanagou; M Pallasopoulou; Ch Lampropoulou-Karatza
Journal:  Am J Med Sci       Date:  2008-07       Impact factor: 2.378

10.  Presence of HCV-RNA after ultracentrifugation of serum samples during the follow-up of chronic hepatitis C patients with a sustained virological response may predict reactivation of hepatitis C virus infection.

Authors:  I Castillo; J Bartolomé; J A Quiroga; G Barril; V Carreño
Journal:  Aliment Pharmacol Ther       Date:  2009-06-11       Impact factor: 8.171

View more
  9 in total

1.  Hepatobiliary quiz-12 (2014).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-12

Review 2.  Epidemiology of hepatitis C virus in Iran.

Authors:  Reza Taherkhani; Fatemeh Farshadpour
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

3.  IL-28B genetic variation, gender, age, jaundice, hepatitis C virus genotype, and hepatitis B virus and HIV co-infection in spontaneous clearance of hepatitis C virus.

Authors:  Sergii V Fedorchenko; Anna Klimenko; Tetyana Martynovich; Olga Liashok; Vitaliy Yanchenko
Journal:  Turk J Gastroenterol       Date:  2019-05       Impact factor: 1.852

4.  Detection of residual HCV-RNA in patients who have achieved sustained virological response is associated with persistent histological abnormality.

Authors:  Yijin Wang; Huiying Rao; Xiumei Chi; Boan Li; Hongyang Liu; Liyuan Wu; Hao Zhang; Shuhong Liu; Gaungde Zhou; Na Li; Junqi Niu; Lai Wei; Jingmin Zhao
Journal:  EBioMedicine       Date:  2019-07-23       Impact factor: 8.143

5.  Evaluation of hepatitis C viral RNA persistence in HIV-infected patients with long-term sustained virological response by droplet digital PCR.

Authors:  Mario Frías; Antonio Rivero-Juárez; Francisco Téllez; Rosario Palacios; Álvaro Jiménez-Arranz; Juan A Pineda; Dolores Merino; María Amparo Gómez-Vidal; Inés Pérez-Camacho; Ángela Camacho; Antonio Rivero
Journal:  Sci Rep       Date:  2019-08-29       Impact factor: 4.379

6.  Recurrence of Cryoglobulinemia Secondary to Hepatitis C in a Patient with HCV RNA (-) Negative in the Serum.

Authors:  Małgorzata Sikorska-Wiśniewska; Katarzyna Sikorska; Anna Wróblewska; Tomasz Liberek; Agnieszka Perkowska-Ptasińska; Alicja Dębska-Ślizień
Journal:  Case Rep Nephrol Dial       Date:  2021-06-14

Review 7.  A New Twist to a Chronic HCV Infection: Occult Hepatitis C.

Authors:  Bashar M Attar; David Van Thiel
Journal:  Gastroenterol Res Pract       Date:  2015-06-24       Impact factor: 2.260

8.  Occult hepatitis C virus infection in patients with malignant lymphoproliferative disorders.

Authors:  Abeya A Lotfi; Asmaa E Mohamed; Nahela A Shalaby; Deena S Eissa; Ehab El-Dabaa; Ayman M Sallam; Mahmoud M Kamel; Hisham Abdelaziz; Amal M El-Afifi; Ahmed S Abdel-Moneim
Journal:  Int J Immunopathol Pharmacol       Date:  2020 Jan-Dec       Impact factor: 3.219

Review 9.  Occult Infection with Hepatitis C Virus: Looking for Clear-Cut Boundaries and Methodological Consensus.

Authors:  Anna Wróblewska; Krzysztof Piotr Bielawski; Katarzyna Sikorska
Journal:  J Clin Med       Date:  2021-12-14       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.